Inflammation and cytokine production by visceral adipose tissues might lead to alternations of inhibitor of nuclear factor-κBβ (IκBβ) and peroxisome proliferator-activated receptor (PPAR) signaling, which are potential therapeutic targets for insulin resistance and chemoprevention of CRC. Here, NFKBIB is linked to colorectal carcinoma.